biosynthesis from 4-hydroxybenzoate (4-HB). We now show that the mitochondrial ferredoxin Yah1p and the ferredoxin reductase Arh1p are required for Q 6 biosynthesis, probably for the first hydroxylation of the pathway. Conditional Gal-YAH1 and Gal-ARH1 mutants accumulate 3-hexaprenyl-4-hydroxyphenol and 3-hexaprenyl-4-aminophenol. Paraaminobenzoic acid (pABA) is shown to be the precursor of 3-hexaprenyl-4-aminophenol and to compete with 4-HB for the prenylation reaction catalyzed by Coq2p. Yeast cells convert U-( 13 C)-pABA into 13 C ring-labeled Q 6 , a result which identifies pABA as a new precursor of Q 6
Summary
Yeast ubiquinone or coenzyme Q 6 (Q 6 ) is a redox active lipid with a crucial role in the mitochondrial electron transport chain. At least nine proteins (Coq1p-9p) participate in Q 6 biosynthesis from 4-hydroxybenzoate (4-HB). We now show that the mitochondrial ferredoxin Yah1p and the ferredoxin reductase Arh1p are required for Q 6 biosynthesis, probably for the first hydroxylation of the pathway. Conditional Gal-YAH1 and Gal-ARH1 mutants accumulate 3-hexaprenyl-4-hydroxyphenol and 3-hexaprenyl-4-aminophenol. Paraaminobenzoic acid (pABA) is shown to be the precursor of 3-hexaprenyl-4-aminophenol and to compete with 4-HB for the prenylation reaction catalyzed by Coq2p. Yeast cells convert U-
Introduction
Coenzyme Q (ubiquinone or Q) is a lipophilic organic molecule composed of a substituted benzoquinone and a polyprenyl chain containing 6 units in Saccharomyces cerevisiae (Q 6 ) and 10 in humans (Q 10 ). Q has a well known role as an electron carrier in the mitochondrial respiratory chain and also functions as a membrane soluble antioxidant (Bentinger et al., 2007) . Moreover, Q has been implicated in modulating the permeability of transition pores (Fontaine and Bernardi, 1999) and is an obligatory cofactor for the proton transport function of uncoupling proteins (Echtay et al., 2001 ).
4-hydroxybenzoate (4-HB) is the long-known aromatic precursor of the benzoquinone ring of Q (Olson et al., 1963; Rudney and Parson, 1963) . Cells synthesize Q from 4-HB and from dimethylallyl diphosphate and isoprenyl diphosphate, the building blocks for the polyprenyl chain. After covalent linkage of the polyprenyl tail to 4-HB to form 3-polyprenyl-4-hydroxybenzoate, a total of 1 decarboxylation, 3 hydroxylation and 3 methylation reactions at the aromatic ring are necessary to yield Q (Figure 1 ). Current knowledge of the genes involved in Q biosynthesis in eukaryotes is mostly derived from the work carried out on yeast by C. Clarke (Tran and Clarke, 2007) . So far, 9 genes (COQ1-9) have been characterized as essential for Q biosynthesis in yeast but only 6 gene products have been assigned a catalytic role ( Figure 1) (Kawamukai, 2009 ). All S. cerevisiae COQ1-9 genes have human relatives.
Primary Q 10 deficiency, a rare recessive disorder, has now been linked to mutations in five genes: PDSS1 (Mollet et al., 2007) and PDSS2 (Lopez et al., 2006; Mollet et al., 2007) ,which are the relatives of COQ1 ; COQ2 (Mollet et al., 2007) ; COQ9 (Duncan et al., 2009 ) and ADCK3/CABC1 the relative of COQ8 (Lagier-Tourenne et al., 2008; Mollet et al., 2008) .
Genetic and biochemical data have shown in yeast that a multi-protein Q biosynthetic complex forms and associates with the mitochondrial inner membrane on the matrix side (Tran and Clarke, 2007) . The proteins Coq3, Coq4, Coq6, Coq7 and Coq9 are part of the Q biosynthetic complex (Tran and Clarke, 2007) and steady state levels of these proteins are strongly decreased in any coq null mutants that lack one of the COQ genes (Tran and Clarke, 2007) . This explains why yeast coq mutants rarely accumulate biosynthetic Q intermediates that may be diagnostic of the altered reaction in a particular mutant. Indeed, yeast null coq3 to coq9 mutants accumulate the same early intermediate 3-hexaprenyl-4-hydroxybenzoate (HHB) (Figure 1 ). Only selective mutations altering the activity of a Coq protein without drastically affecting assembly of the Q biosynthetic complex may lead to accumulation of intermediates different from HHB. Only 2 such intermediates have been unambiguously identified and linked to a mutation in a COQ gene: 5-demethoxyubiquinone (DMQ 6 ) accumulates in two coq7 mutants, L237Stop and E233K (Padilla et al., 2004) , and 3-hexaprenyl-4,5-dihydroxybenzoate accumulates in an uncharacterized coq3 mutant strain (Clarke et al., 1991) . The rare occurrence of intermediates diagnostic of the defective step in Q biosynthesis largely explains why the order of reactions modifying the aromatic ring of 4-polyprenyl-3 hydroxybenzoate is still speculative (Tran and Clarke, 2007) .
Coq6p and Coq7p are two mono-oxygenases that function of Q biosynthesis. Coq7p hydroxylates DMQ 6 (Padilla et al., 2004; Tran et al., 2006) and Coq6p may catalyse one or both of the two remaining hydroxylation steps (Gin et al., 2003) (Figure 1 ). Mono-oxygenases are widely distributed proteins that catalyze incorporation of one oxygen atom into substrates.
Dioxygen is the source of the oxygen atom and mono-oxygenases usually employ a transition metal (iron, copper) or an organic cofactor (flavin, pterin) to mediate dioxygen activation at their active site. This activation requires two electrons which are provided by a reductant. NAD(P)H can directly reduce the flavin cofactor of flavoprotein mono-oxygenases whereas reduction of the heme iron in cytochrome P450 type oxygenases is accomplished by an associated reductase (Ballou et al., 2005; Munro et al., 2007 The Yah1p/Arh1p system is located in the mitochondrial matrix and is required for viability (Barros and Nobrega, 1999; Manzella et al., 1998) . Yah1p and Arh1p play an essential role in the biogenesis of Fe-S clusters (Lange et al., 2000; Li et al., 2001 ) and of heme A (Barros et al., 2002) , an indispensable cofactor of cytochrome c oxidase. Cox15p which catalyzes the conversion of heme O to heme A is the likely recipient of electrons transferred by Yah1p (Barros et al., 2002) whereas the recipient is still unknown for the biogenesis of Fe-S clusters. Conserved motifs in the primary sequence of Coq6p and Coq7p predict that these two mono-oxygenases employ a flavin and a di-iron cofactor respectively (Gin et al., 2003; Stenmark et al., 2001) . The oxidized flavin of Coq6p is a two-electron acceptor whereas the oxidized di-iron (Fe   III   -Fe   III   ) center of Coq7p will also accept two electrons but one at a time. Therefore the putative direct two-electron reduction of the flavin of Coq6p by hydride transfer from NAD(P)H is not applicable to the di-iron center of Coq7p.
The in vivo source of electrons used by Coq7p is still unknown and we hypothesized that the Yah1p/Arh1p system may fulfill this role.
In this work, we show that the Yah1p/Arh1p system is essential for yeast Q 6 synthesis. Cells depleted for Yah1p or Arh1p accumulate specific intermediates of Q 6 upstream of DMQ 6 , the substrate of Coq7p. The accumulation of these early intermediates pointed to the involvement of Yah1p/Arh1p in the first hydroxylation reaction of Q 6 biosynthesis. Surprisingly, one of the intermediates accumulated in Yah1p-depleted cells contains an amine group. This observation led us to show that para-aminobenzoic acid (pABA) is the precursor of this intermediate and that pABA enters the Q biosynthetic pathway at the prenylation reaction catalyzed by Coq2p. Moreover, labeling experiments proved that pABA is an in vivo precursor of the benzoquinone ring of Q 6 . This new, unexpected role of pABA has been overlooked since the discovery of 4-HB as the precursor of the benzoquinone ring of Q more than 40 years ago.
Results
The mitochondrial ferredoxin Yah1p and its associated reductase Arh1p are essential for Q 6 biosynthesis In order to test the possible role of the mitochondrial ferredoxin Yah1p in Q 6 biosynthesis, we used the strain Gal-YAH1 in which the native YAH1 promoter was replaced by the GAL10 promoter (Lange et al., 2000) . Therefore, the expression of the essential YAH1 gene in the Gal-YAH1 strain is under the control of a galactose-inducible promoter (Lange et al., 2000) .
When YAH1 expression was repressed by cultivating the Gal-YAH1 strain in a glucosecontaining medium, we noted a strong depletion of the Q 6 content of the cells together with that of DMQ 6 (Figure 2A ). Q 6 and DMQ 6 were detected electrochemically after separation of cell lipid extracts by HPLC. Surprisingly, we detected an additional electroactive compound eluting at around 610 seconds which was absent from the galactose-grown cells (Figure 2A ).
The striking decrease of Q 6 does not result from dying cells because the cells were viable at the end of the glucose culture as assessed by determining the colony forming units on galactose medium. Introduction of a plasmid carrying the YAH1 gene in the Gal-YAH1 strain restored wild-type Q 6 levels in glucose-grown cells and abolished the accumulation of the electroactive compound ( Figure 2B ). To verify that the [2Fe-2S] cluster of Yah1p was required for Q 6 generation, we constructed mutant alleles of Yah1p in which conserved Fe-S cysteine ligands (C103 and C106) are mutated to alanine ( Figure S1 ) (Xia et al., 1996) . The electrochromatograms of extracts from glucose-grown Gal-YAH1 strains containing an empty vector and from C103A or C103-106S mutants of Yah1p were similar, with an accumulation of the newly detected metabolite, showing that these cysteines are essential for Yah1p function ( Figure 2B and data not shown). The Fe-S center of Yah1p is reduced by electrons provided by the ferredoxin reductase Arh1p which is also an essential protein (Manzella et al., 1998) . In order to corroborate the observation that Yah1p is required for Q 6 biosynthesis, we generated a Gal-ARH1 strain in which the expression of ARH1 is repressed by growth in glucose medium. After growth of the Gal-ARH1 strain in glucose medium, Arh1p was undetectable in purified mitochondria but Yah1p steady state level was only mildly decreased ( Figure 2C ). These mitochondria showed little Q 6 and accumulated the electroactive compound found in Yah1p-depleted mitochondria ( Figure 2D ). Altogether, these results show that the absence of a functional ferredoxin / ferredoxin reductase system strongly depletes cellular and mitochondrial levels of Q 6 and promotes the accumulation of a novel compound. or COQ7 in the Gal-YAH1 strain prevented the accumulation of the electroactive compound upon depletion of Yah1p ( Figure 3A and data not shown). This result suggests that the electroactive compound is part of the Q 6 pathway and is formed downstream of HHB.
In order to determine whether the compound is produced during the Q 6 biosynthetic pathway or is a degradation product of Q 6 , we exploited a strain which accumulates mostly DMQ 6 instead of Q 6 . This strain contains a chromosomal insertion of a sequence coding for a triple hemagglutinin (3HA) epitope tag on the 3'end of COQ7. The presence of the 3HA epitope on the C terminus of Coq7p likely causes the partial inactivation of the protein as evidenced by the accumulation of large amounts of DMQ 6 as compared to Q 6 ( Figure 3B ) .
Depletion of Yah1p in a Gal-YAH1 COQ7-3HA strain resulted in a strong decrease of DMQ 6 and still promoted the accumulation of the electroactive compound eluting at around 610 s ( Figure 3B ). This result demonstrates that this compound is not a degradation product of Q 6 and strongly suggests that it originates from Q 6 biosynthesis at a step prior to the hydroxylation of DMQ 6 catalyzed by Coq7p.
We purified the compound in its reduced form, analyzed it by high resolution mass spectrometry and obtained a m/z ratio of 518.43610 (M+H + Figure S2A ). Tropylium and pyrilium ions are typically observed upon fragmentation of Q 6 (m/z 197 and 237) and DMQ 6 (m/z 167 and 207) (Padilla et al., 2004) .
The fragmentation observed on the spectrum in Figure S2B is consistent with the successive loss of methine, methylene or methyl groups of the hexaprenyl chain, the lightest fragment (162.0915) corresponding to C 10 H 12 NO. Both fragmentation spectra are indicative of the presence of a hexaprenyl chain in the C 36 H 55 NO molecule.
We next characterized the purified C 36 H 55 NO molecule by NMR spectroscopy. The resulting 1 H NMR spectrum shows well-defined peaks with some of them easily attributable to the hexaprenyl moiety (methyl, methylene and vinylic protons) ( Figure 3C and experimental procedures). The aromatic region shows three massifs (6.67 to 6.61 ppm, 6.57 to 6.54 ppm and 6.52 to 6.46 ppm) of equal intensity all situated at rather high field for aromatic protons ( Figure 3D ). These results strongly suggest the presence of three electro-donating substituents on the aromatic ring. Moreover, the observed multiplicity associated with the value of the coupling constants unambiguously establishes both meta and para substitutions.
Finally, the aromatic region of the spectrum was compared to that of the commercially available 3-methyl-4-aminophenol ( Figure 3D ). Both spectra were almost super-imposable, with identical pattern and coupling constants and slightly different chemical shifts. The UVvisible absorption spectra of the reduced and oxidized forms of the purified compound and of 3-methyl-4-aminophenol show identical absorbance maxima ( Figure S2C and S2D). All these results unambiguously identify 3-hexaprenyl-4-aminophenol as the electroactive compound accumulated in Yah1p-deficient cells ( Figure 3E ). For the sake of simplicity, the numbering of the aromatic carbon atoms of the different Q 6 intermediates throughout this manuscript will be as in Figure 3E .
pABA is the precursor of 3-hexaprenyl-4-aminophenol and competes with 4-HB for prenylation by Coq2
The presence of a nitrogen atom in a product synthesized in vivo by the Q 6 biosynthetic pathway was surprising. Indeed, C, H and O atoms are the only constituents of the different intermediates of Q biosynthesis described to date ( Figure 1 ). Para-aminobenzoic acid (pABA) is structurally close to para-hydroxybenzoic acid (4-HB), the precursor of the aromatic ring of Q ( Figure 1 ). We therefore hypothesized that the 3-hexaprenyl-4-aminophenol synthesized in the Yah1p-deficient strain might originate from pABA. The accumulation of 3-hexaprenyl-4-aminophenol increased in the Gal-YAH1 strain upon addition of pABA to YP-glucose (YPD) medium ( Figure 4A ) showing that pABA is the precursor of 3-hexaprenyl-4-aminophenol. We also consistently detected more 3-hexaprenyl-4-aminophenol when the Gal-YAH1 strain was cultured in glucose synthetic complete (SC-2% glu) medium compared to YPD (compare Figure 4A and 4B). This is likely because pABA is an ingredient of synthetic medium at 0.2mg/L.
pABA being a precursor of 3-hexaprenyl-4-aminophenol suggested that pABA is prenylated by the polyprenyl transferase Coq2p, which is known to prenylate 4-HB.
Decreased levels of 3-hexaprenyl-4-aminophenol were observed in the Gal-YAH1 strain when 4-HB was added to the culture medium ( Figure 4B ) suggesting a competition between pABA and 4-HB for prenylation by Coq2p. Addition of 3,4-dihydroxybenzoic acid was without an effect on the accumulation of 3-hexaprenyl-4-aminophenol (data not shown).
A coq5 strain accumulates HHB, the product of the prenylation of 4-HB catalyzed by Coq2p ( Figure 1 ) (Tran and Clarke, 2007) . Esterification of HHB with diazomethane stabilizes HHB and facilitates its detection by mass spectrometry (Poon et al., 1995 observed mass, 560.42113; ppm, 3.2) was detected spectroscopically eluting at 620 s in chromatograms of diazomethane-treated extracts of the coq5 strain ( Figure 4C ), and was found to be absent from extracts of the WT strain or from untreated extracts (data not shown).
pABA supplementation increased the accumulation of 3-hexaprenyl-4-aminobenzoic acid methylester (HABme) (M= C 38 H 57 NO 2 : 559.43890; observed mass, 559.43931; ppm, 0.7) eluting at 570 s in diazomethane-treated extracts of the coq5 strain ( Figure 4C ). HABme was also absent from extracts of the WT strain or from untreated extracts (data not shown). It is apparent in Figure 4C that pABA supplementation increases HABme and decreases HHBme whereas 4-HB supplementation increases HHBme and decreases HABme. This shows that pABA and 4-HB are competing substrates for the prenylation reaction catalyzed by Coq2p.
Concomitant accumulation of 3-hexaprenyl-4-hydroxyphenol and 3-hexaprenyl-4-
aminophenol by the Yah1p-deficient strain.
SC medium contains pABA which efficiently competes with 4-HB for the prenylation reaction. In order to check if a compound originating from 4-HB may form within the Yah1p-deficient strain, we cultured the Gal-YAH1 strain in YPD instead of SC medium ( Figure 2A ).
Together with 3-hexaprenyl-4-aminophenol at 610 s, we detected an electroactive compound eluting at 800 s in extracts of the Gal-YAH1 strain cultured in YPD ( Figure 5A and Figure   4A ). The purified compound yielded a pseudo-molecular ion at m/z 519. Figure   S3A ). UV-Vis spectra of the C 36 H 54 O 2 molecule are similar to the ones of methyl-1,4-benzoquinone ( Figure S3B and S3C respectively). These results in addition to the fact that the C 36 H 54 O 2 molecule is not formed in either the Gal-YAH1 coq5 or Gal-YAH1 coq7 cells (data not shown) strongly suggest that 3-hexaprenyl-4-hydroxyphenol is the electroactive compound eluting at 800 s ( Figure 5B ).
This conclusion was further substantiated by the finding that 4-HB is the precursor of 3-hexaprenyl-4-hydroxyphenol. Indeed, addition of 4-HB to YPD medium increased 3-hexaprenyl-4-hydroxyphenol and decreased 3-hexaprenyl-4-aminophenol in the Yah1p-deficient strain ( Figure 5C ). In contrast, addition of pABA increased the quantity of 3-hexaprenyl-4-aminophenol as noted earlier ( Figure 4A ), but also decreased the production of 3-hexaprenyl-4-hydroxyphenol ( Figure 5C ). This competition between pABA and 4-HB for the formation of 3-hexaprenyl-4-aminophenol and 3-hexaprenyl-4-hydroxyphenol parallels the one observed for the biosynthesis of 3-hexaprenyl-4-aminobenzoic acid and 3-hexaprenyl-4-hydroxybenzoic acid ( Figure 4C ).
pABA is a precursor of Q 6
We have shown that 3-hexaprenyl-4-aminophenol and 3-hexaprenyl-4-aminobenzoic acid originate from pABA, suggesting that pABA enters the Q 6 biosynthetic pathway ( Figure   4A and 4C). In order to check if pABA may be a precursor of Q 6 like 4-HB, we synthesized U-( 13 C)-pABA from U-( 13 C)-toluene in three steps ( Figure S4 and Supplemental experimental procedures). As expected, culture of the Gal-YAH1 strain in YPD containing U-( 13 C)-pABA predominantly yielded 13 C 6 -labeled 3-hexaprenyl-4-aminophenol at m/z 524.4 (data not shown). A WT strain was cultured in YPD supplemented with 2mg/L of U-( 13 C)-pABA and Q 6 was purified. The mass spectrum of this purified Q 6 showed two peaks of comparable abundance at m/z 591.4 and 597.4 ( Figure 6A ), corresponding respectively to unlabeled Q 6 and 13 C ring-labeled Q 6 . This result clearly shows that pABA is a precursor of Q 6 in yeast. In order for pABA to be converted into Q 6 , the amine group must be replaced by an hydroxyl group during the Q 6 biosynthetic pathway after the formation of 3-hexaprenyl-4-aminobenzoate. The COQ7-3HA strain mostly accumulated DMQ 6 instead of Q 6 ( Figure 3B ).
The mass spectrum of DMQ 6 purified from the COQ7-3HA strain grown in YPD We next cultured the W303 WT strain in synthetic medium lacking pABA. To our surprise, cells grown in pABA-free medium accumulated 8 to 10 fold less Q 6 than cells grown in rich (YP) medium or in synthetic medium ( Figure 6B ). Addition of 0.2 mg/L of pABA to pABA-free medium yields synthetic medium and restored normal levels of Q 6 ( Figure 6B ).
pABA and 4-HB were equally efficient to support Q 6 synthesis when added to pABA-free medium. These results illustrate our conclusion that pABA is a precursor of Q 6 and support the idea that most of the Q 6 synthesized by yeast grown in synthetic medium actually originates from the pABA present in the growth medium. In order to determine whether S.
cerevisiae uses endogenous pABA for Q 6 biosynthesis, we cultured the Gal-YAH1 strain in pABA-free medium containing 2% galactose and then in pABA-free medium containing 2%
glucose. 3-Hexaprenyl-4-aminophenol was detected in cell lipid extracts (data not shown),
showing that endogenously synthesized pABA enters the Q biosynthetic pathway.
Discussion
In this work, we show that the mitochondrial ferredoxin Yah1p and its reductase Arh1p, the yeast homologues of mammalian Adx and AdxR, are essential for Q biosynthesis in yeast. Strains depleted for any of these two essential proteins have a strongly reduced content of Q 6 and accumulate 3-hexaprenyl-4-aminophenol and 3-hexaprenyl-4-hydroxyphenol ( Figure 5C ). 3-hexaprenyl-4-aminophenol results from the prenylation of pABA by Coq2p whereas prenylation of 4-HB, the long known ring precursor of Q, will ultimately produce 3-hexaprenyl-4-hydroxyphenol ( Figure 7 paths 1 and 4, respectively).
pABA and 4-HB differ only by one substituent of benzoic acid, an amine or an hydroxyl group, and both molecules originate in E. coli and yeast from chorismate, a product of the shikimate pathway. In agreement with our results, pABA has previously been shown to be prenylated by orthologs of Coq2p in E. coli and rat as evidenced by the observation of 3-polyprenyl-4-aminobenzoic acid (Hamilton and Cox, 1971 ) (Alam et al., 1975) . pABA can therefore enter the Q biosynthetic pathway in many organisms but are these organisms capable of converting 3-polyprenyl-4-aminobenzoic acid into Q? Our work clearly shows that, in yeast, 3-hexaprenyl-4-aminobenzoic acid is converted to Q 6 since addition of U-( 13 C)-pABA to the growth medium of WT yeast strain promotes the biosynthesis of 13 C 6 labeled Q 6
( Figure 6A and Figure 7 path 2). pABA is likely not a precursor of Q in E. coli because a mutant strain deficient in chorismate synthetase activity synthesized Q upon supplementation of the growth medium with 4-HB but not with pABA, despite the formation of 3-polyprenyl-4-aminobenzoic acid (Hamilton and Cox, 1971) . Our results with yeast warrant a thorough investigation to determine whether mammalian cells can convert pABA into Q. In vitro experiments by Rudney and collaborators on rat liver demonstrated that pABA is converted to 3-polyprenyl-4-aminobenzoic acid and suggested that this compound was further modified although not into Q (Alam et al., 1975) . Therefore pABA has been considered an inhibitor of Q biosynthesis in mammals but only a limited decrease of Q was observed in cancer cells upon culture in a high concentration of pABA (Brea-Calvo et al., 2006) .
In view of our observation that Q 6 levels drop dramatically when yeast is cultured in pABA-free medium, it is reasonable to postulate that most of the Q 6 produced by yeast cultured in SC medium originates from the pABA present in this growth medium. Our results suggest that in pABA-free medium the rate-limiting step of Q 6 biosynthesis is the availability of the ring precursors of Q, 4-HB and pABA. Endogenous levels of these molecules allow the synthesis of only 1.4 pmoles of Q 6 /mg of wet cells under our non-repressive culture conditions. One can then question the physiological significance of the high levels of Q 6 (12-16 pmoles of Q 6 /mg of wet cells) synthesized by yeast grown in SC medium or rich medium.
Actually, several authors have shown that only a small percentage of the Q 6 synthesized in these growth media is sufficient to sustain respiratory growth (Mollet et al., 2008; Tran et al., 2006) , suggesting that, under normal conditions, Q 6 is in vast excess for its function as an electron carrier in the respiratory chain. Our results also provide a possible explanation as to why, contrary to E. coli, mutants affecting 4-HB synthesis may not abrogate yeast Q 6 biosynthesis and therefore not result in a respiratory deficient phenotype. Previously, authors have speculated that yeast may produce 4-HB by multiple ways; from chorismate via the chorismate pyruvate-lyase reaction similar to the E. coli pathway and from tyrosine like in higher eukaryotes (Clarke, 2000) . However, none of the enzymes responsible for these reactions have been identified in yeast. The fact that pABA can be used in Q 6 biosynthesis like 4-HB and that pABA is present in standard yeast culture media imply that pABA may support biosynthesis of Q 6 in a yeast mutant blocked for the synthesis of 4-HB when cultured in standard conditions.
The conversion of pABA into Q 6 suggests an additional step in Q 6 biosynthesis: the replacement of the amine by an hydroxyl group at C4 (Figure 7 path 2). This reaction certainly takes place downstream of the hexaprenylation reaction catalyzed by Coq2p since 3-hexaprenyl-4-aminobenzoic acid was detected in a coq5 strain ( Figure 4C ). The formation of 13 C 6 -DMQ 6 upon supplementation of the growth medium with U-( 13 C)-pABA proves that the C4 aromatic NH 2 -to-OH conversion occurs prior to the formation of DMQ 6 . The accumulation of 3-hexaprenyl-4-aminophenol in the Yah1p-depleted strain suggests that this reaction occurs after the C1 hydroxylation step. Alternatively, the presence of the amine group at this stage may simply result from the lack of hydroxylation of the adjacent C5 position. Indeed, based on the example of bacterial anthranilate and aniline dioxygenases, which catalyze the conversion of aromatic amines into ortho-catechols (Beharry et al., 2003 ) (Ang et al., 2007) , the NH 2 -to-OH substitution on C4 may occur together with the hydroxylation on C5. The NH 2 -to-OH conversion reaction is chemically challenging and future studies will have to elucidate this newly evidenced process in Q 6 biosynthesis.
What is the role of Yah1p/Arh1p in Q 6 biosynthesis? Deficiency in any of these two
proteins results in accumulation of 3-hexaprenyl-4-amino/hydroxyphenol. In order to form 3-hexaprenyl-4-amino/hydroxyphenol from 3-hexaprenyl-4-amino/hydroxybenzoic acid, the decarboxylation and hydroxylation at position 1 must occur without hydroxylation of C5
( Figure 7 , paths 1 and 4). Therefore the most upstream reaction of the Q 6 biosynthetic pathway to be inhibited in the absence of Yah1p/Arh1p is the C5 hydroxylation of 3-hexaprenyl-4-amino/hydroxybenzoic acid. The identity of the mono-oxygenase that catalyzes the C5 hydroxylation is currently unknown. Coq6p has been initially proposed to catalyze either the C5 or C1 hydroxylations or both (Gin et al., 2003) . Our results strongly argue for the involvement of Coq6p in only one of the two reactions since the C1 hydroxylation still proceeds in the Yah1p/Arh1p-depleted strains whereas the C5 hydroxylation does not. Coq6p sequence contains conserved motifs characteristic for flavin-dependent mono-oxygenases such as 4-hydroxybenzoate hydroxylase (Gin et al., 2003) . Reduction of the FAD cofactor at the active site of 4-hydroxybenzoate hydroxylase has been extensively studied and shown to proceed via a direct hydride transfer from NADPH (Ballou et al., 2005) . By analogy,
NAD(P)H is the likely electron donor to Coq6p, making the hydroxylation catalyzed by Coq6
independent of the Yah1p/Arh1p reducing system. We thus propose that the C1 hydroxylation which is unaffected by depletion of Yah1p/Arh1p is catalyzed by Coq6p (Figure 7 ). This point is difficult to prove since a coq6 strain, like the other coq3 to coq9 null mutants, accumulates only HHB because of the instability of the Q biosynthetic complex (Gin et al., 2003; Hsieh et al., 2007) . The involvement of Coq6p in the C1 hydroxylation implies that the C5 hydroxylation is catalyzed by an unknown oxygenase which may require an electron transport machinery like Yah1p/Arh1p. This scenario would explain why the C5 hydroxylation is abrogated upon depletion of Yah1p or Arh1p.
How to explain that the reactions after the C1 hydroxylation (C2 methylation by In conclusion, our study has unraveled that pABA serves as a precursor of Q 6 similar to 4-HB whose role in Q biosynthesis was identified more than forty years ago. We also demonstrated that the yeast Adx/AdxR homologs Yah1p/Arh1p are required for the first hydroxylation reaction of the yeast Q 6 biosynthetic pathway, which represents a new function for these proteins. In the light of these results, it seems important to evaluate whether these new actors of yeast Q 6 biosynthesis play a role in mammalian Q biosynthesis.
Significance
Coenzyme Q is a redox active lipid that functions in electron transport chains in cellular membranes and also has an important antioxidant function. Q is a prenylated benzoquinone which biosynthesis starts with the assembly of a polyprenyl chain and its conjugation to 4-HB, the precursor of the benzoquinone moiety (Turunen et al., 2004 ). Here we demonstrate that yeast can convert pABA into Q making of pABA a new precursor of Q, like the longknown 4-HB. Our finding thus implies that an aromatic NH 2 -to-OH conversion must occur to synthesize Q from pABA. The reducing system formed by the mitochondrial ferredoxin Yah1p and its associated reductase Arh1p is essential for Fe-S cluster biosynthesis (Lange et al., 2000; Li et al., 2001) . 
Experimental Procedures
Yeast strains and culture conditions: Yeast strains used in this study are listed in Table S1 .
Yeast strains were transformed using lithium acetate. A 3HA epitope tag was inserted on the 3' end of COQ7 ORF by PCR as described previously (Longtine et al., 1998) to create the COQ7-3HA strain. This strain was crossed with the Gal-YAH1 gene to isolate the COQ7-3HA
Gal-YAH1 strain by selecting the corresponding markers after tetrad dissection. The coq5∆
Gal-YAH1 and coq7∆ Gal-YAH1 strains were obtained in a similar way. In Gal-ARH1, the upstream region from ARH1 was exchanged for the galactose-inducible GAL-L promoter by PCR mediated DNA replacement (Janke et al., 2004) .Yeast media were supplemented with either 2% glucose or 2% galactose. Synthetic medium consisted in 1.7g/L YNB and 5g/L ammonium sulfate and the appropriate nutrients to complement strains auxotrophies.
Synthetic complete (SC) medium was obtained by adding 2g/L Drop-out mix Synthetic minus
Ade, His, Leu, Trp, Ura (US Biological) to synthetic medium. YNB without pABA and folate was from MP Biomedicals and was supplemented with 5ug/L folate. Rich YP medium was prepared as described (Sherman, 2002) . Gal-YAH1 and Gal-ARH1 strains were maintained and precultured on galactose medium. Depletion of Yah1p was accomplished by diluting 300
fold the preculture into glucose containing medium and growing the cells for 18 hours at 30°C. Depletion of Arh1p required two subsequent dilutions in glucose medium.
Plasmids : YAH1 ORF with its own promoter (380bp) and terminator (150bp) was cloned into pRS416 using XhoI and SacI. This vector served as a template to generate the C103A and C103,106S mutants by site directed mutagenesis. Sequencing was used to confirm cloning products in all created vectors. The E. coli strain DH5 was used for plasmid DNA amplification.
Miscellaneous biochemical analysis: Isolation of yeast mitochondria and immunostaining
were performed as described (Diekert et al., 2001 ) (Harlow and Lane, 1988) .
Lipid extraction and quantification of electroactive compounds by HPLC-ECD (electrochemical detection):
Lipid extraction and analyses of quinone content were essentially as described (Tran et al., 2006) .100 uL glass beads, 50uL H 2 O and Q 4 (used as an internal standard) were added to mitochondria (100ug mitochondrial proteins) or to cell pellets (40mg wet weight). Tubes were wrapped in foil and lipids were extracted by adding 0.6 mL methanol and 0.4 mL petroleum ether and by vortexing for 3 minutes. The phases were separated by centrifugation (3 min at 1000 × g, 4 °C). The upper petroleum ether layer was transferred to a fresh tube. 0.4 mL petroleum ether was added to the glass bead-methanol containing tube and the extraction was repeated 2 more times. The petroleum ether layers were combined and dried under nitrogen. The lipids were resuspended in 100 uL mobile phase (98% methanol, 20mM lithium perchlorate) and aliquots were analyzed by reversedphase high pressure liquid chromatography with a C18 column (Betabasic-18, 5 µm, 4.6 × 150 mm, Thermo Scientific) at a flow rate of 1 ml/min. Quinones were quantified with an ESA Coulochem II electrochemical detector and a 5011A analytical cell (E1, -500 mV; E2, 500 mV). Hydroquinones present in samples were oxidized with a pre-column 5020 guard cell set in oxidizing mode (E, +550 mV). The maximum output signal of the analytical electrode E2 was set to +10V and was recorded by a 4 channel signal recorder USB10 (Velleman instruments). The Q 4 external standard was used to correct for sample loss during the organic extraction based on its recovery (always greater than 85%). Esterification and analysis of 3-hexaprenyl-4-aminobenzoate and 3-hexaprenyl-4-hydroxybenzoate: Dried lipid extracts from yeast cells (700mg wet weight) were resuspended in 400uL anhydrous diethyl ether. 150uL of diazomethane (0.2 M in diethyl ether) was added, the mixture was incubated for 8 minutes at room temperature and the reaction was quenched by adding 10uL of glacial acetic acid. Samples were dried under nitrogen and HPLC analysis was carried out as described for quinone content quantification except that the signal recorded was the absorbance at 273nm.
Mass spectrometry
For high resolution mass spectrometry analyses, samples in methanol were diluted in 90% acetonitrile, 0.2% formic acid and were infused into the nanospray source of a discovery ORBITRAP instrument (Thermo Fischer Scientific) at a flow rate of 0.5uL min -1 . The MS method used a scan range of 150-1600 m/z and was composed of MS and MS/MS events using both the Orbitrap as the analyzer (at a resolution of 30000) to get high precision on the molecular and on the fragments ions. The CID fragmentation collision energy used was set to 35 eV and the MS/MS scan range to 100-2000 m/z. QualBrowser from XCalibur was used to read the spectra.
Analyses involving coupling of HPLC to mass spectrometry were performed with an series 1100 Agilent chromatographic system associated to SCIEX API 3000 triple quadrupolar mass spectrometer. Separation was performed on an octadecylsilyl ODB Uptisphere column (150×2 mm ID, 5 µm particle size, Montluçon, France), using a gradient of acetonitrile in 2 mM ammonium formate. MS2 spectra were obtained by selecting pseudomolecular ion in quadrupole 1 and fragmenting it in the collision cell. The fragmentation spectrum was recorded in the 50-520 mass unit range. Tran, U.C., Marbois, B., Gin, P., Gulmezian, M., Jonassen, T., and Clarke, C.F. Supplemental information includes four figures, one table, supplemental experimental procedures and references: Figure S1 relates to the mutants of Yah1p in Figure 2B . Figure S2 corresponds to additional characterization of the compound displayed in Figure 3E . Figure S3 corresponds to additional characterization of the compound displayed in Figure 5B . Figure S4 shows the chemical synthesis of labeled pABA used in Figure 6A . Table S1 contains the yeast strains used in this study.
Supplemental experimental procedures include the description of the chemical synthesis of labeled pABA ( Figure S4 ) and the purification of 3-hexaprenyl-4-aminophenol ( Figure 3E ).
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Figure S4 or methyl groups of the hexaprenyl chain. B) UV-Vis spectra of a similar quantity of purified 3-hexaprenyl-4-hydroxyphenol (3H4Hphe) after chromatography on the HPLC column with the precolumn electrode set at +600mV (ox) or -500mV (red). C) UV-Vis spectra of 1 nmole of methyl-1,4-benzoquinone (M1,4benzoQ) after chromatography on the HPLC column with the precolumn electrode set at +600mV (ox) or -1000mV (red). Figure S4 : Chemical synthesis of U-( 13 C)-p-aminobenzoic acid. The detailed protocol is described in the supplemental experimental procedures. Table S1 : S. cerevisiae strains used in this study
